sorafenib has been researched along with l 778,123 in 1 studies
Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (l 778,123) | Trials (l 778,123) | Recent Studies (post-2010) (l 778,123) |
---|---|---|---|---|---|
6,520 | 730 | 5,251 | 15 | 0 | 5 |
Protein | Taxonomy | sorafenib (IC50) | l 778,123 (IC50) |
---|---|---|---|
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Bos taurus (cattle) | 0.0485 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Homo sapiens (human) | 0.3319 | |
Protein farnesyltransferase subunit beta | Bos taurus (cattle) | 0.0485 | |
Protein farnesyltransferase subunit beta | Homo sapiens (human) | 0.402 | |
Geranylgeranyl transferase type-1 subunit beta | Homo sapiens (human) | 0.0983 | |
Protein farnesyltransferase subunit beta | Rattus norvegicus (Norway rat) | 0.0036 | |
Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Rattus norvegicus (Norway rat) | 0.0036 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Korzeniecki, C; Priefer, R | 1 |
1 review(s) available for sorafenib and l 778,123
Article | Year |
---|---|
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.
Topics: Humans; Models, Molecular; Molecular Structure; Mutation; Protein Kinase Inhibitors; Proto-Oncogene Proteins p21(ras); Signal Transduction | 2021 |